Bryce Haymond

Art America shop:

[Bryce Haymond @brycehaymond]

@Delta hey, just tried to book a flight on Delta and it declined our city / zip code. USPS added the 84048 zip code to Lehi, Utah, a few months ago. You might want to add that zip code to your systems or you won't be getting business from anyone in our zip code.

[Bryce Haymond @brycehaymond]

@jie_liu1 Looks like it is still going from top to bottom as it refines the image.

[Bryce Haymond @brycehaymond]

@lepadphone Perhaps something like the Hybrid Autoregressive Transformer (HART) method developed by MIT and NVIDIA? "Their hybrid... uses an autoregressive model to quickly capture the big picture and then a small diffusion model to refine the details of the image."
https://t.co/JZ65bKGXsH

[Bryce Haymond @brycehaymond]

@reveimage my generations seem to be using 3 credits each. I thought it might be aspect ratio of 3:2, so I switched to 1:1, and still they are using 3 credits each. Can you explain how credits are calculated, because it is not 1 credit per image. Does enhance use more?

[Bryce Haymond @brycehaymond]

Here's an uncropped version.

[Bryce Haymond @brycehaymond]

Google's new native image generation/editing in Gemini 2.0 Flash can do some pretty cool direct editing of images. I took the Library of Congress's "photograph" of Joseph Smith, told it to colorize and modernize it. Then I did some Photoshopping, and 2x upscaled it.

[Bryce Haymond @brycehaymond]

@googleaistudio why doesn't Google AI Studio allow Gemma 3 to receive image inputs? Isn't it multimodal?

[Bryce Haymond @brycehaymond]

@openrouter why can't I send images to Gemma 3? I get a code 400 error with "Image input modality is not enabled for models/gemma-3-27b-it"

[Bryce Haymond @brycehaymond]

...If health insurance doesn't cover such evidence-based standard of care treatments as determined by the consensus of medical experts, what good is it for? They have betrayed their primary purpose, and have become a barrier to healthcare, not a facilitator of it.

[Bryce Haymond @brycehaymond]

It is day 55 since our "health insurance" Regence BlueCross BlueShield of Utah @RegenceUtah began denying coverage for the critical cancer drug Perjeta (pertuzumab) in my wife Raven's adjuvant breast cancer treatment...

[Bryce Haymond @brycehaymond]

...Despite all that, Regence has the audacity to repeatedly assert that this treatment is "investigational."...

[Bryce Haymond @brycehaymond]

...with clinical trials showing clear benefits in reducing recurrence risk (metastasis), and so it is STRONGLY recommended as the standard of care of every major clinical oncology guideline in the world (NCCN, ASCO, NICE, ESMO).

Still waiting on our appeal to external review.

[Bryce Haymond @brycehaymond]

It is day 54 since our "health insurance" Regence BlueCross BlueShield of Utah @RegenceUtah began denying coverage for the critical cancer drug Perjeta in my wife Raven's breast cancer treatment, as prescribed by her oncologist, with full FDA approval since 2017...

[Bryce Haymond @brycehaymond]

...Still waiting on our appeal to external review.

[Bryce Haymond @brycehaymond]

It is day 53 since our "health insurance" Regence BlueCross BlueShield of Utah @RegenceUtah began denying coverage for the critical cancer drug Perjeta in my wife Raven's breast cancer treatment, as prescribed by her oncologist, with full FDA approval since 2017...

[Bryce Haymond @brycehaymond]

...for this exact protocol, with clinical trials showing clear benefits in reducing recurrence risk (metastasis) and improving overall survival, and so it is STRONGLY recommended as the standard of care of every major clinical guideline in the world (NCCN, ASCO, NICE, ESMO, JBCS)

[Bryce Haymond @brycehaymond]

...They have upheld their denials of this standard of care treatment several times now, and our appeals are now at the final level—external review.

[Bryce Haymond @brycehaymond]

Day 52 since our "health insurance" Regence BlueCross BlueShield of Utah @RegenceUtah began denying coverage for the critical cancer drug Perjeta in my wife Raven's breast cancer treatment, as prescribed by her oncologist, with full FDA approval since 2017 for this exact protocol

[Bryce Haymond @brycehaymond]

...with clinical trials showing clear benefits in reducing recurrence risk (metastasis) and improving overall survival, and so it is STRONGLY recommended as the standard of care of every major clinical oncology guideline in the world (NCCN, ASCO, NICE, ESMO, JBCS)...